πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8747863

Vaccine for shigella

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741309

Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741313

Polypeptide vaccine and vaccination strategy against mycobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741306

Kidney specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8734778

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8710185

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8709813

DNA promoters and anthrax vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697856

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8668911

Streptococcus vaccine compositions and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8647637

Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circu

The Board of Regents for Oklahoma State University Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8647633

Recombinant F1-V plague vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637049

Attenuated live vaccines for aquatic animals

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637026

Anti-C35 antibody combination therapies and methods

VACCINEX, INC. Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637050

Peptide vaccines against group A streptococci

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8629260

Anti-arthropod vector vaccines, methods of selecting and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8609404

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8603808

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8591890

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment mo

University of Connecticut Health Center Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575319

Cleavable vaccine compositions and uses thereof and methods of making and using the same

The Regents of the University of California Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8535687

Smallpox DNA vaccine and the antigens therein that elicit an immune response

Inovio Pharmaceuticals, Inc. Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501194

Vaccine for viruses that cause persistent or latent infections

The Regents of the University of California Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501926

Malaria vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8496938

Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

VACCINEX, INC. Β· Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted